Business Day TV speaks to Mike Simpson, CEO of IntriHEALTH
The world’s largest maker of hearing aids expects its sales to grow by 6%-9%
The company has been grappling with an anticorruption campaign targeting the bribing of doctors
Private hospital operator predicts growth in revenue of up to 4.4% at the halfway stage
Danish drugmaker’s shares rise 260% since Wegovy’s US launch
Several items affected the results including the completion of the sale of AMG
The medical devices maker agrees to settle all personal injury claims in the country, ending uncertainty that had slashed its market value
The conglomerate has nevertheless maintained its earnings forecast
Cybersecurity firm targets platforms that offer GLP-1 drugs such as Ozempic and Mounjaro
The reconstituted exco will continue to be led by Peter Wharton-Hood as the CEO.
The pharmaceutical group has received the necessary regulatory approvals from Chinese authorities to conclude two linked transactions
The company is in the process of delisting and shareholders have been offered 80c per share
Council for Medical Schemes claims board was unlawfully elected
SA’s high TB burden and strong clinical trial infrastructure allows it to play a key role in the trial, which aims to enrol 20,000 volunteers
Icon has clinical protocols, formularies and funding models used by more than half the medical scheme market
Drugmaker is also considering partnership with a retail pharmacy to offer a collect option for customers
The ENSafrica investigation included interviews with hospital staff and a review of more than 120,000 emails and documents
The company is racing to increase output of the weight-loss drug Wegovy amid shortages
Drugmaker expects to finalise deals within the next six months to help use idle capacity
